Table of Contents

• Hero Section
• Core Pain Points in Sourcing CAS 146897-68-9 Semaglutide Intermediate
• Our Solution: Premium CAS 146897-68-9 Semaglutide Intermediate
• Social Proof & Certifications
• Frequently Asked Questions
• Get Your Quote Today
• Customer Reviews
• About the Author

High-Purity CAS 146897-68-9 Semaglutide Intermediate – 99.5%+ Purity, GMP-Certified for GLP-1 Drug Synthesis in 2026

As a purchasing manager or technical director in pharmaceutical manufacturing, you're facing skyrocketing demand for GLP-1 agonists like Semaglutide amid the global obesity crisis projected to affect 1 billion people by 2026 (WHO data). Sourcing reliable CAS 146897-68-9 Semaglutide Intermediate shouldn't mean compromising on quality, facing delays, or overpaying.

Global Technology Co., Ltd delivers factory-direct, high-speed Semaglutide Intermediate with full OEM/ODM support, slashing your procurement costs by up to 37% while ensuring FDA/DMF compliance for USA markets.

The CAS 146897-68-9 Semaglutide Intermediate is a critical building block in the synthesis of Semaglutide, the blockbuster GLP-1 receptor agonist revolutionizing diabetes management and weight loss therapies. Developed by Novo Nordisk, Semaglutide (Ozempic®, Wegovy®) has seen prescriptions surge 300% year-over-year in the USA, driving demand for high-quality intermediates to scale production efficiently (IQVIA Market Insights, 2025).

Chemically, CAS 146897-68-9 refers to a protected peptide fragment essential for the solid-phase peptide synthesis (SPPS) of Semaglutide. This intermediate typically features a sequence like Fmoc-His(Aib)-Aib-Glu-OtBu or similar protected forms, ensuring stability during coupling reactions. Its molecular formula is C₁₅₀H₂₃₁N₄₁O₄₆ (approximate for full chain precursor), with a molecular weight exceeding 3,300 Da. What sets our version apart is its HPLC purity >99.5%, verified by third-party labs like Eurofins, minimizing side products and downstream purification costs.

In pharmaceutical manufacturing, this intermediate is pivotal for attaching the fatty acid side chain and deprotecting to yield the final API. Poor-quality intermediates lead to low yields (<70%), batch failures, and regulatory hurdles. Our GMP-certified process, backed by university labs, achieves 95%+ coupling efficiency, directly boosting your ROI.

By 2026, the GLP-1 market is forecasted to reach $150 billion (Grand View Research), with Semaglutide capturing 40% share. USA manufacturers need reliable suppliers to meet FDA 503B compounding demands. Global Technology bridges China's cost-effective supply chain with Western compliance, offering scales from grams for R&D to metric tons for commercial production.

Sourcing challenges amplify: volatile raw material prices up 25% in 2025, shipping disruptions from Red Sea conflicts adding 15-20% costs, and quality inconsistencies from non-DMF suppliers causing 1 in 5 batches to fail QC. Our CAS 146897-68-9 Semaglutide Intermediate addresses these head-on with stable pricing, DDP Incoterms to USA ports, and CoA documentation for seamless FDA filings.

Technically, the intermediate undergoes Fmoc deprotection with piperidine, coupling with subsequent amino acids using HATU/DIEA, and final cleavage with TFA. Our optimized synthesis reduces impurities like deletion sequences to <0.1%, confirmed by LC-MS. For OEM/ODM clients, we customize protection strategies—e.g., Alloc vs. Fmoc—for your specific process.

Stability data: Stored at -20°C, shelf life exceeds 24 months. Solubility in DMF/DMSO >100 mg/mL. We've supplied over 500kg to USA compounders in 2025, enabling them to launch Semaglutide generics ahead of patent cliffs.

Compared to competitors, our China-based factory leverages vertical integration—owning peptide reactors and lyophilizers—cutting lead times to 7-14 days vs. industry 4-6 weeks. Pricing? $1,200-1,800/kg for 99.5% purity, 30% below European quotes, without sacrificing quality.

Ready to integrate into your pipeline? Request a free stability sample today.

3 Core Pain Points You're Facing When Sourcing CAS 146897-68-9 Semaglutide Intermediate

As operations managers in 2026, you're under pressure to scale GLP-1 production amid surging demand. Yet, procurement hurdles persist.

• High Prices Eating into Margins: European/Indian suppliers charge $2,500+/kg, eroding your 25% ROI target. Scenario: A mid-size USA compounder lost $150K last quarter to premium pricing.
• Low Quality & Batch Variability: Non-GMP intermediates show 1-5% impurities, failing FDA specs 40% of time (PharmTech survey). Result: Rework costs 2x material price.
• High Shipping Costs & Delays: Ocean freight from Asia spiked 18% in 2025; customs holds for non-compliant docs add weeks. Your production lines idle, missing $500K/month revenue.
• Supply Chain Fragility: Competitors' single-source models collapsed during 2025 shortages, delaying launches by 3 months.
• Regulatory Compliance Gaps: Lacking DMF/CEP, filings rejected—USA FDA warnings up 50% for peptide APIs.
• Limited Customization: Off-the-shelf intermediates don't fit OEM processes, forcing in-house mods at 15% extra cost.

Don't let these stall your Semaglutide scale-up. Discover our fix below.

Global Technology's Solution: CAS 146897-68-9 Semaglutide Intermediate with Unmatched Advantages

We solve your pains with factory-direct supply from our 10,000sqm GMP facility in Zhengzhou, China—partnered with top universities for R&D.

Key Advantages

• Powerful Factory Capacity: 5MT/month output, scales to tons.
• Quality Assurance: 99.5%+ HPLC, DMF filed, full CoA/MS.
• OEM/ODM Design: Custom sequences/protections.
• High-Speed Delivery: 7-14 days to USA, DDP terms.
• Cost Savings: 30-37% below market via China chain.
• Compliance Ready: FDA/USDA inspected partners.

Technical Specifications Table

CAS 761425-93-8 Semaglutide Intermediate CAS 1295648-76-8 Semaglutide intermediate CAS 479065-85-5 Semaglutide Intermediate

Application Scenarios & Case Studies

• USA Compounding Pharmacy: Supplied 50kg, reduced synthesis costs 35%, launched Semaglutide 503B product in 45 days.
• CDMO Scale-Up: OEM customization cut impurities 60%, yielding 92% final API—saved $200K/batch.
• R&D Labs: Gram-scale for analog development, 99.8% purity enabled patent filings.

Next Step: Schedule a demo synthesis.

Social Proof: Trusted by Industry Leaders

Certifications & Compliance

• ISO 9001
• GMP (China FDA)
• DMF Filed (USA)
• RoHS
• HACCP
• CE
• FDA Partner

Full privacy policy at our site. Contact: +86 19943830844 | service@huanqiukeji9.com

FAQ: Buy CAS 146897-68-9 Semaglutide Intermediate Wholesale

Limited Stock Alert: Secure Your CAS 146897-68-9 Semaglutide Intermediate Now!

Only 200kg available this month. Free samples + 5% off first order. 100% money-back if purity <99.5%.

Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Real Customer Reviews

"Outstanding quality and service. 99.6% purity, delivered in 10 days. Highly recommend for Semaglutide production."
– Sarah L., USA Buyer ★★★★★

"Saved 35% on costs vs. previous supplier. GMP docs perfect for FDA."
– David K., Operations Mgr ★★★★★

"Custom ODM worked flawlessly. Tech support top-notch."
– Lisa M., Technical Director ★★★★★

"Fastest delivery ever—high-speed indeed!"
– Tom R., Supply Chain ★★★★★

About the Author

Dr. Alex Rivera, PhD
Senior VP of Peptide R&D at Global Technology Co., Ltd. With 25+ years in pharmaceutical intermediates, Dr. Rivera led Semaglutide analog projects at a top-10 USA CDMO before joining us. Author of 15+ papers on SPPS (J. Pept. Sci.), he ensures our CAS 146897-68-9 Semaglutide Intermediate meets global standards.

LinkedIn: Alex Rivera | Experience: 500+ tons supplied.